MERIDIAN BIOSCIENCE, INC. — Revenue by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/25e68238-fa03-49b4-8d09-fc248dfa5b58/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2022$333.0M2021-10-01 – 2022-09-30evidence 0001193125-22-290521
FY 2021$317.9M2020-10-01 – 2021-09-30evidence 0001193125-21-337663
FY 2020$253.7M2019-10-01 – 2020-09-30evidence 0001193125-20-300813
FY 2019$201.0M2018-10-01 – 2019-09-30evidence 0001193125-19-300565
FY 2018$213.6M2017-10-01 – 2018-09-30evidence 0001193125-19-300565
FY 2017$200.8M2016-10-01 – 2017-09-30evidence 0001193125-19-300565
FY 2016$196.1M2015-10-01 – 2016-09-30evidence 0001193125-18-337257
FY 2015$194.8M2014-10-01 – 2015-09-30evidence 0001193125-15-390041
FY 2014$188.8M2013-10-01 – 2014-09-30evidence 0001193125-14-428676
FY 2013$188.7M2012-10-01 – 2013-09-30evidence 0001193125-13-457721
FY 2012$172.7M2011-10-01 – 2012-09-30evidence 0001193125-13-457721
FY 2011$158.8M2010-10-01 – 2011-09-30evidence 0001193125-13-457721
FY 2010$143.0M2009-10-01 – 2010-09-30evidence 0000950123-10-109251
FY 2009$148.3M2008-10-01 – 2009-09-30evidence 0000950123-10-109251
FY 2008$139.6M2007-10-01 – 2008-09-30evidence 0000950123-10-109251
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

MERIDIAN BIOSCIENCE, INC. — all facts · Net Income · Operating Income